Bodal Chemicals Share Price
174.95-9.19 (-4.99%)
+186.38% past 1 Year
Prices are delayed by 1 hour. Login or Sign Up for live updates.Prices are delayed by 1 hour. Login or Sign Up for live updates.
Price Analysis
Share Price Live Stats
No results found
Share Market Cap & Key Ratios Overview
No results found
About
No results found
Stock Analysis (SWOT)
QVT
Peer Stocks
1 week
1 month
1 year
No results found
Bodal Chemicals Share Price
174.95-9.19 (-4.99%)
+186.38% past 1 Year
Financial overview
Peer Comparison
Profit & Loss
Consolidated
Standalone
Quarterly
Yearly
₹
%
Balance Sheet
Consolidated
Standalone
₹
%
Cash Flow
Consolidated
Standalone
₹
%
Fundamental Ratios
Consolidated
Standalone
Bodal Chemicals Share Price
174.95-9.19 (-4.99%)
+186.38% past 1 Year
Technical meters
No results found
Pivot
High & lows
1 Day
1 Week
1 Month
3 Months
6 Months
Year to Date
1 Year
3 Years
5 Years
10 Years
All Time
Bodal Chemicals Share Price
174.95-9.19 (-4.99%)
+186.38% past 1 Year
Shareholding summary
Shareholding Pattern
Quarterly
Yearly
No results found
Bulk & block deals
No results found
Insider trading & SAST
No results found
Bodal Chemicals Share Price
174.95-9.19 (-4.99%)
+186.38% past 1 Year
Corporate Actions
Date
Type
Details
Company details
Bodal Chemicals Share Price
174.95-9.19 (-4.99%)
+186.38% past 1 Year
Corporate filings & documents
No corporate filings & documents found
Bodal Chemicals Share Price
174.95-9.19 (-4.99%)
+186.38% past 1 Year
News
TCS Sees Seasonal Q3 Furloughs as AI Revenue Crosses 10 Percent
Equity
TCS
TCS Maintains Long Term Margin Goal Despite Near Term Investment Pressure
Equity
TCS
TCS Expects International Growth And Seasonal Consumer Business Improvement
Equity
TCS
GST Council Proposes Five Percent Rate Option For Electric Passenger Transport Services
Broader Market
CDSCO Reviews Disposal Framework For Equipment From Closed Pharma Units
Broader Market
Highway Infra Secures Rs 24.46 Crore NHAI Toll Operations Contract
Equity
HILINFRA
Jefferies Sees Manageable Hospital Margin Impact From Cancer Drug Price Cap
Broader Market
Kotak Securities upgrades KEC International to Add with Rs 400 target
Equity
KEC
Goldman Sachs Sees Limited Earnings Impact From Anti Cancer Drug Margin Cap
Broader Market
US PERM Suspension Seen Having Limited Impact On Indian IT Firms
Broader Market
UBS Initiates Buy Rating On LG Electronics India With Rs 2,100 Target
Equity
LGEINDIA
UBS Maintains Buy Rating On Blue Star With Rs 2,000 Target Price
Equity
BLUESTARCO
Kotak Maintains Add On TCS After In Line Second Quarter Performance
Equity
TCS
CLSA Maintains Hold On TCS As Margin Recovery Remains Uncertain
Equity
TCS
JPMorgan Maintains Overweight Rating On TCS With Rs 2,300 Target
Equity
TCS
Nomura Maintains Buy Rating On TCS With Rs 2,630 Target Price
Equity
TCS
HSBC Maintains Hold On TCS After Mixed Second Quarter Results
Equity
TCS
Citi Retains Sell Rating On TCS As Growth And Margins Remain Under Pressure
Equity
TCS
Goldman Sachs Maintains Buy On TCS Despite Margin And Deal Win Concerns
Equity
TCS
Citi Maintains Buy Rating On Info Edge With Rs 1,510 Target Price
Equity
NAUKRI